Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Forbes contributors publish independent expert analyses and insights. Kathleen Walch covers AI, ML, and big data best practices. Jun 04, 2025, 03:32am EDT AI is helping reshape how buildings are ...
To meet the growing demand for high-performance, lightweight, and intelligent materials in the aerospace, automotive, and energy/power sectors, engineering ...
News-Medical.Net on MSN
New AI framework enables reliable intracellular antibody design
A new artificial intelligence-driven pipeline developed in a collaborative research combines protein structure prediction, sequence design, and live-cell screening together to enable rapid conversion ...
AI-driven generative design automates the exploration of thousands of design permutations, significantly reducing development cycles and costs. Integration of simulation and manufacturing constraints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results